Fig. 2From: Recombinant human plasma gelsolin reverses increased permeability of the blood–brain barrier induced by the spike protein of the SARS-CoV-2 virus3D blood–brain barrier model. A Schematic of a microfluidic device with the location of inlet/outlet ports and ports to fill the hydrogel reservoir. B Picture of the PDMS device. Scale bar, 1 cm. C Permeability testing with 4 kDa Dextran-FITC configuration. D TEER measurementsBack to article page